The brand drugs division of Impax Labs has finished enrolling patients in a late-stage clinical...
Patients who had not received previous treatment recovered and healed better when taking a Johnson...
The Food and Drug Administration has approved a generic injectable drug made by Sagent Pharmaceuticals...
Presenters from Pfizer’s cancer drugs unit will have a lot of work to do at...
The Food and Drug Administration will start phasing out asthma and chronic obstructive pulmonary disease...
The Food and Drug Administration has approved a drug for diseases that affect the pancreas,...
Javelin Pharmaceuticals has dropped an acquisition deal with Myriad Pharmaceuticals in favor of one with...
New healthcare legislation, the aging U.S. population and a shortage of primary care physicians will...
An investigational drug made by Novartis for multiple sclerosis reduced annual relapse rates in new...
Many people who have traveled in the developing world know the feeling of eating a...
Patients who used a drug by UCB for treating restless legs syndrome showed sustained improvements...
Upsher-Smith Labs has acquired exclusive North American rights for an investigational drug designed to treat...
Patients with chronic genotype 1 hepatitis C fared better when given an investigational drug developed...
Though it has existed for nearly 200 years, the drug colchicine now has clinical data...
Drug maker Keryx Biopharmaceuticals has started registration for a late-stage clinical trial of a pill...
One of the nation's largest specialty pharmacy groups is expecting a record turnout for its...
A biotech company has granted rights to its vaccine-development platform to a government-funded effort to...
A specialty pharmaceutical company that develops innovative drug delivery technologies has appointed a new VP...
The market for drugs to treat ovarian cancer will more than triple during the period...
The Food and Drug Administration has granted fast-track review to an investigational drug by Keryx...
Par Pharmaceuticals has reached a settlement with Sanofi-Aventis in a case concerning a generic cancer...
A patch for treating pain associated with shingles made by NeurogesX now is available, the...
MDRNA plans to buy Cambridge, Mass.-based Cequent Pharmaceuticals for $46 million, the biotech company announced...
A court has upheld Eli Lilly’s patent on an injected drug for treating cancer, the...
Pharmaceutical sales are on the rise, as 2009 saw drug sales almost three times as...